Page 88 - Predicting survival in patients with spinal bone metastasesL
P. 88
CHAPTER VI
cancer (n=388, 28%), lung cancer (n=318, 23%), prostate cancer (n=259, 19%), kidney cancer (n=90, 7%) and colon cancer (n=73, 5%). The remaining 18% consisted of 16 different primary tumors (table 2).
Table 1. Patient characteristics. SD: standard deviation.
Characteristic
N (%)
Sex Male
Female
Age (years, mean ± SD)
Location treated spinal metastasis
Cervical Cervicothoracic Thoracic Thoracolumbar Lumbar
Diffuse
Number spinal metastases
One
Two
Three or more
Number extraspinal bone metastases None
718 (52)
661 (48) 64.6 ± 12.4
53 (4)
63 (5) 376 (27) 351 (25) 332 (24) 204 (15)
415 (30) 234 (17) 730 (53)
466 (44) 336 (24) 577 (42)
22 (2) 518 (37) 466 (34) 294 (21) 30 (2) 49 (4)
611 (44) 768 (56)
8 (<1)
8 (<1) 143 (10) 464 (34) 746 (55) 10 (<1)
1141(83) 33 (2) 109 (8) 96 (7)
1043 (76) 336 (24)
One or two
Three or more
Karnofsky performance status
100 80-90 60-70 40-50 10-30 Missing
Visceral/Brain metastases Present
Not present
Frankel score A
B
C
D
E Missing
Treatment
Radiotherapy
Surgery
Radiotherapy and surgery Palliative/conservative
Hospital Leiden Graz
ECOG performance status 0
1
2
3
4 Missing
86
